Cargando…

Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer

Detalles Bibliográficos
Autores principales:	Jo, Jung Ki, Oh, Jong Jin, Kim, Yong Tae, Moon, Hong Sang, Choi, Hong Yong, Park, Seunghyun, Ho, Jin-Nyoung, Yoon, Sungroh, Park, Hae Young, Byun, Seok-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112751/ https://www.ncbi.nlm.nih.gov/pubmed/30159135 http://dx.doi.org/10.18632/oncotarget.25970

Ejemplares similares

A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer
por: Jo, Jung Ku, et al.
Publicado: (2017)

Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study
por: Oh, Jong Jin, et al.
Publicado: (2017)

A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients
por: Oh, Jong Jin, et al.
Publicado: (2015)

Prognostic Value of Body Mass Index in Korean Patients with Castration-Resistant Prostate Cancer
por: Park, Jeong Min, et al.
Publicado: (2012)

Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population
por: Oh, Jong Jin, et al.
Publicado: (2017)

The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients
por: Oh, Jong Jin, et al.
Publicado: (2014)

Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort
por: Park, Jae Young, et al.
Publicado: (2017)

Initial Biopsy Outcome Prediction in Korean Patients-Comparison of a Noble Web-based Korean Prostate Cancer Risk Calculator versus Prostate-specific Antigen Testing
por: Park, Jae Young, et al.
Publicado: (2011)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy
por: Kim, Ki Bom, et al.
Publicado: (2015)

The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy
por: Kim, Dae Keun, et al.
Publicado: (2010)

Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
por: Kim, Yejin, et al.
Publicado: (2016)

ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score
por: Oh, Jong Jin, et al.
Publicado: (2021)

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer
por: Yun, Seok Joong, et al.
Publicado: (2017)

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy
por: Kang, Minyong, et al.
Publicado: (2015)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
por: Lin, Ting-Ting, et al.
Publicado: (2019)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

Darolutamide For Castration-Resistant Prostate Cancer
por: Bastos, Diogo A, et al.
Publicado: (2019)

SETD1A Promotes Proliferation of Castration-Resistant Prostate Cancer Cells via FOXM1 Transcription
por: Yang, Liu, et al.
Publicado: (2020)

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
por: Pak, Sahyun, et al.
Publicado: (2022)

Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians
por: Sureka, Sanjoy Kumar, et al.
Publicado: (2016)

Evaluation of Polygenic Risk Scores for Prediction of Prostate Cancer in Korean Men
por: Oh, Jong Jin, et al.
Publicado: (2020)

Prediction of clinically significant prostate cancer using polygenic risk models in Asians
por: Song, Sang Hun, et al.
Publicado: (2022)

The Prostate Health Index and multi-parametric MRI improve diagnostic accuracy of detecting prostate cancer in Asian populations
por: Ye, Changhee, et al.
Publicado: (2022)

Optimal treatment for castration-resistant prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2014)

Reappraisal of glucocorticoids in castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Chemotherapy options in castration-resistant prostate cancer
por: Teply, Benjamin A., et al.
Publicado: (2016)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
por: Montgomery, Bruce, et al.
Publicado: (2010)

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
por: Ojo, Diane, et al.
Publicado: (2015)

Castration for Prostatic Hypertrophy
Publicado: (1899)

A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer
por: Kim, Hae Su, et al.
Publicado: (2017)

Establishment of Korean prostate cancer database by the Korean Urological Oncology Society
por: Ahn, Hanjong, et al.
Publicado: (2017)

Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer
por: Pascoe, Abigail C, et al.
Publicado: (2012)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells
por: Lin, Xiao-Dan, et al.
Publicado: (2021)

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
por: Choi, Yoon Ji, et al.
Publicado: (2018)

Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer
por: Xu, Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5klt6qndqj0cja39hf8m5gkq8g